Please assess the completion status of the following clinical trial:

Trial Title: Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female, 18 years of age or older.~* Ulcerative colitis described according to usual criteria, diagnosed for at least 1 year.~* Oral maintenance treatment with 5-ASA only for at least 3 months with a dosage of 2 to 3 g/day.~* Clinical remission for at least 3 months (Mayo Clinic score) and endoscopic remission (endoscopic score of Mayo Clinic) at inclusion.~* Signed informed consent form.~Exclusion Criteria:~* Patients allergic to aspirin or salicylates derivatives~* Patients taking the following treatments during the study will be excluded: corticosteroids (oral or rectal route), use of NSAID or Aspirin, any form of sulfasalazine, mesalazine or 4-ASA.~* Patients with known significant hepatic or known function abnormalities and/or creatine clearance ≤ 80 ml/min.~* Patients with history or physical examination findings indicative of active alcohol or drug abuse.~* Women who are pregnant or nursing.~* Patients with a history of disease, including mental/emotional disorder that would interfere with their participation in the study.~* Patients who participated in another clinical study in the last 3 months.~* Patients who are unable to comply with the requirements of the protocol~* Female of childbearing potential without efficacious contraception.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).